BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8450610)

  • 1. [Testicular relapse, with Ph-positive chromosome after bone marrow transplantation for acute lymphocytic leukemia].
    Koike M; Hino K; Onizuka T; Sato S; Akimoto Y; Nakamaki T; Ishiyama T; Tomoyasu S; Tsuruoka N
    Rinsho Ketsueki; 1993 Jan; 34(1):63-7. PubMed ID: 8450610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolated testicular relapse after bone marrow transplant with total body irradiation and testicular boost in acute lymphoblastic leukemia.
    Li CK; Shing MM; Chik KW; Kwan WH; Lai DH; Leung TF; Yuen PM
    Bone Marrow Transplant; 1998 Aug; 22(4):397-9. PubMed ID: 9722077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The incidence of testicular recurrence in boys with acute leukemia treated with total body and testicular irradiation and stem cell transplantation.
    Quaranta BP; Halperin EC; Kurtzberg J; Clough R; Martin PL
    Cancer; 2004 Aug; 101(4):845-50. PubMed ID: 15305418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow transplantation for Philadelphia-chromosome-positive acute lymphoblastic leukemia.
    Stockschläder M; Hegewisch-Becker S; Krüger W; tom Dieck A; Mross K; Hoffknecht M; Berger C; Kohlschütter B; Martin H; Peters S
    Bone Marrow Transplant; 1995 Nov; 16(5):663-7. PubMed ID: 8547863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolated testicular relapse in a boy with acute lymphoblastic leukemia following allogeneic bone marrow transplantation.
    Conter V; Rabbone ML; Jankovic M; Rossi MR; Placa F; Mazzola P; Uderzo C; Masera G
    Haematologica; 1989; 74(5):507-9. PubMed ID: 2511123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful prevention of hematological relapse for a patient with Philadelphia chromosome-positive acute lymphoblastic leukemia after allogeneic bone marrow transplantation by donor leukocyte infusion.
    Yazaki M; Andoh M; Ito T; Ohno T; Wada Y
    Bone Marrow Transplant; 1997 Feb; 19(4):393-4. PubMed ID: 9051252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Need for an accurate molecular diagnosis to assess the donor origin of leukemia relapse after allogeneic stem cell transplantation.
    Spinelli O; Giussani U; Borleri G; Lazzari M; Michelato A; Dotti G; Barbui T; Rambaldi A
    Haematologica; 2000 Nov; 85(11):1153-7. PubMed ID: 11064467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The monitoring of BCR-ABL mRNA by reverse transcription PCR in patients undergoing allogeneic bone marrow transplantation for acute lymphoblastic leukemia with a positive Philadelphia chromosome].
    Román J; Castillejo JA; Jiménez A; Maldonado J; Torres A
    Med Clin (Barc); 1999 Dec; 113(20):779-82. PubMed ID: 10680143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolated testicular leukemia following bone marrow transplant for acute lymphocytic leukemia. The need for pretransplant testicular biopsies.
    Cairo M; Weetman RM; Baehner RL
    Am J Pediatr Hematol Oncol; 1982; 4(1):41-4. PubMed ID: 7046495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allogeneic bone marrow transplantation for children with acute leukemia: long-term follow-up of patients prepared with high-dose cytosine arabinoside and fractionated total body irradiation.
    Gordon BG; Warkentin PI; Strandjord SE; Abromowitch M; Bayever E; Harper JL; Coccia PF
    Bone Marrow Transplant; 1997 Jul; 20(1):5-10. PubMed ID: 9232249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allogeneic bone marrow transplantation (BMT) for adults with acute lymphoblastic leukemia (ALL): predictive role of minimal residual disease monitoring on relapse.
    Miglino M; Berisso G; Grasso R; Canepa L; Clavio M; Pierri I; Pietrasanta D; Gatto S; Varaldo R; Ballerini F; Verdiani S; Casarino L; DeStefano F; Sessarego M; Dominietto A; Raiola AM; Bregante S; di Grazia C; Gobbi M; Bacigalupo A
    Bone Marrow Transplant; 2002 Nov; 30(9):579-85. PubMed ID: 12407432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone marrow transplant indications for childhood leukemias: achieving a consensus. The EBMT Pediatric Diseases Working Party.
    Dini G; Cornish JM; Gadner H; Souillet G; Vossen JM; Paolucci P; Manfredini L; Miano M; Niethammer D
    Bone Marrow Transplant; 1996 Nov; 18 Suppl 2():4-7. PubMed ID: 8932789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continued complete remission without systemic therapy for isolated testicular relapse after bone marrow transplantation in a boy with acute lymphoblastic leukemia.
    Kodama Y; Okamoto Y; Ijichi O; Shinkoda Y; Nishikawa T; Tanabe T; Yoshioka T; Tashiro Y; Mougi H; Kawano Y
    Pediatr Transplant; 2009 Sep; 13(6):769-72. PubMed ID: 19067929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes.
    Slavin S; Naparstek E; Nagler A; Ackerstein A; Kapelushnik J; Or R
    Exp Hematol; 1995 Dec; 23(14):1553-62. PubMed ID: 8542946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allogeneic peripheral blood progenitor cells for treatment of relapse after bone marrow transplantation.
    Glass B; Majolino I; Dreger P; Scimè R; Santoro A; Vasta S; Suttorp M; Haferlach T; Schmitz N
    Bone Marrow Transplant; 1997 Oct; 20(7):533-41. PubMed ID: 9337054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of allogeneic bone marrow transplantation for acute leukemia have improved in Europe with time--a report of the acute leukemia working party of the European group for blood and marrow transplantation (EBMT).
    Frassoni F; Labopin M; Gluckman E; Prentice HG; Vernant JP; Zwaan F; Granena A; Gahrton G; De Witte T; Gratwohl A; Reiffers J; Gorin NC
    Bone Marrow Transplant; 1996 Jan; 17(1):13-8. PubMed ID: 8673048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term results of allogeneic bone marrow transplantation for 108 adult patients with acute lymphoblastic leukemia: favorable outcome with BMT at first remission and HLA-matched unrelated donor.
    Chim CS; Lie AK; Liang R; Au WY; Kwong YL
    Bone Marrow Transplant; 2007 Aug; 40(4):339-47. PubMed ID: 17572712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of clinical utility of minimal residual disease detection in allogeneic stem cell recipients with childhood acute lymphoblastic leukemia: multi-institutional collaborative study in Japan.
    Imashuku S; Terui K; Matsuyama T; Asami K; Tsuchiya S; Ishii E; Kawa K; Kosaka Y; Eguchi H; Tsuchida M; Ikuta K; Kato S; Koizumi S; Okamura J; Morimoto A; Hibi S; Hamaoka K;
    Bone Marrow Transplant; 2003 Jun; 31(12):1127-35. PubMed ID: 12796792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mixed chimerism in the B cell lineage is a rapid and sensitive indicator of minimal residual disease in bone marrow transplant recipients with pre-B cell acute lymphoblastic leukemia.
    Zetterquist H; Mattsson J; Uzunel M; Näsman-Björk I; Svenberg P; Tammik L; Bayat G; Winiarski J; Ringdén O
    Bone Marrow Transplant; 2000 Apr; 25(8):843-51. PubMed ID: 10808205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolated testicular relapse in an adolescent 5 years following allogeneic bone marrow transplantation for acute myelogenous leukemia.
    Lehmann LE; Guinan EC; Halpern SL; Donovan MJ; Bierer BE; Parsons SK
    Bone Marrow Transplant; 1997 Apr; 19(8):849-51. PubMed ID: 9134181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.